| Fang Xiang,Xianli Yin. Progress of transformational therapy in colorectal liver metastases. Oncol Transl Med, 2015, 1: 115-119. |
| 结直肠癌肝转移转化治疗的研究进展 |
| Progress of transformational therapy in colorectal liver metastases |
| Received:March 26, 2015 Revised:June 05, 2015 |
| DOI：10.1007/s10330-015-0083-y |
| 中文关键词: colorectal cancer; liver metastases; colorectal liver metastases (CLM); transformational therapy; Hepatic arterial infusion (HAI); portal vein embolization (PVE); ablation; targeted therapy; cetuximab; bevacizumab |
| 英文关键词: colorectal cancer; liver metastases; colorectal liver metastases (CLM); transformational therapy; Hepatic arterial infusion (HAI); portal vein embolization (PVE); ablation; targeted therapy; cetuximab; bevacizumab |
| 基金项目: |
| Author Name | Affiliation | E-mail | | Fang Xiang | Alimentary and Urological Sistem Neoplasm Department of Internal Medicine, Hunan Tumor Hospital | 6807284@qq.com | | Xianli Yin* | Alimentary and Urological Sistem Neoplasm Department of Internal Medicine, Hunan Tumor Hospital | Yinxianli2009@163.com |
|
| Hits: 8173 |
| Download times: 9842 |
| 中文摘要: |
| Colorectal cancer liver metastases (CLM) treatment is very important given the high incidence of colorectal
cancer with liver metastases, which are primarily treated by surgical resection. Transformational therapy
such as systemic chemotherapy, hepatic arterial infusion (HAI), portal vein embolization (PVE), ablation
therapy, and targeted therapy, should be applied to CLM patients who are unable to undergo immediate
surgery to improve patients’ survival and quality of life. |
| 英文摘要: |
| Colorectal cancer liver metastases (CLM) treatment is very important given the high incidence of colorectal
cancer with liver metastases, which are primarily treated by surgical resection. Transformational therapy
such as systemic chemotherapy, hepatic arterial infusion (HAI), portal vein embolization (PVE), ablation
therapy, and targeted therapy, should be applied to CLM patients who are unable to undergo immediate
surgery to improve patients’ survival and quality of life. |
|
View Full Text
Download reader HTML全文 |
| Close |